Cancer Center Support Grant

摘要 在过去的5年里，该中心在癌症研究和服务方面保持了良好的发展势头， 它的集水区，北卡罗来纳州。随着Sharpless博士被任命为NCI主任， 在与大学领导层和中心的科学顾问协商后，厄普博士被重新任命为 Lineberger综合癌症中心（LCCC）主任连任。LCCC继续其 在过去十年中，在包括国家服务在内的所有重要指标方面都表现出色。直接 2019年癌症研究经费增加到1.61亿美元，其中超过5400万美元来自NCI;中心 主任授权下的研究空间增加了约10，000 nsf;参与干预性试验的人数增加了10，000 nsf。 超过11，000个5年期间的应计项目; 6，000多个癌症相关出版物中的36%是 协作;开始建设GMP设施，并与多个IND启动CAR T计划 社区外展参与办公室扩大了LCCC的传统优势 以社区为基础的参与性研究和实施。 该中心的324名成员涵盖基础，临床和人口科学，分为9个项目， 方案间和方案内生产率很高。物理和药学专业的教师补充 科学在药物发现、输送、成像和早期检测方面创造了新的机会。实质性 对教师、技术和生物信息学的投资极大地扩展了癌症遗传学研究， 在TCGA中的领导地位，以及在临床试验中扩大测序的使用。LCCC人口科学家发起 在癌症结果方面做出了重大的新努力，包括招募和分析所有癌症病例的基础设施， 我们的集水区，以及在癌症交流，健康获取，生存和 分子流行病学乳腺癌少数群体差异研究中的突破性观察出现 中心方案。我们的基本计划继续发布高影响力的观测结果， 转化为人类疗法。跨中心的全球肿瘤学工作在每个NCI的 新的竞争。该中心的持续扩张是由显着的机构支持，包括 州议会对癌症研究的直接支持Lineberger要求继续提供资金 用于：9个科学项目; 13个共享资源;临床方案和数据管理;方案审查和 监测系统、发展基金、规划、领导和评估以及癌症研究和 CCSG预算支持技术和运营扩张， 教师通过癌症中心的机制整合，以促进预防，早期 在北卡罗来纳州和全国范围内检测和治疗癌症。

ABSTRACT Over the past 5 years, the Center sustained its upward trajectory in cancer research excellence and service to its catchment area, the State of North Carolina. With Dr Sharpless’s appointment to NCI Director, in consultation with University leadership and the Center’s Scientific Advisors, Dr Earp was re-appointed UNC Lineberger Comprehensive Cancer Center (LCCC) Director for an additional term. The LCCC continued its exceptional performance of the past decade with respect to all important metrics including state service. Direct cost cancer research funding in 2019 increased to $161M of which over $54M comes from NCI; Center research space under the Director’s authority increased by ~10,000nsf; participation in interventional trials was over 11,000 accruals for the 5 year period; 36% of the more than 6,000 cancer related publication were collaborative; construction of a GMP facility was begun and a CAR T program was initiated with multiple INDs and 8 trials opened; and the Office of Community Outreach Engagement expanded LCCC’s traditional strength in community-based participatory research and implementation . The Center’s 324 members span the basic, clinical and population sciences organized into 9 programs with substantial inter- and intra-programmatic productivity. Faculty additions in the physical and pharmaceutical sciences created new opportunities in drug discovery, delivery, imaging and early detection. Substantial investment in faculty, technology and bioinformatics dramatically expanded cancer genetics research including leadership in the TCGA and expanded use of sequencing in clinical trials. LCCC population scientists initiated significant new efforts in cancer outcomes with recruitment and infrastructure for analyzing all cancer cases in our catchment area, as well as new endeavors in cancer communication, health access, survivorship and molecular epidemiology. Groundbreaking observations in breast cancer minority disparity research emerged from Center programs. Our basic programs continue to publish high-impact observations that are being translated into human therapeutics. A trans-Center Global Oncology effort received grants in each of the NCI’s new competitions. The Center’s continued expansion is driven by remarkable institutional support including direct support for cancer research from the state legislature. The UNC Lineberger requests continued funding for: 9 scientific programs; 13 shared resources; Clinical Protocol and Data Management; Protocol Review and Monitoring System, Developmental Funds, Planning, Leadership and Evaluation and Cancer Research and Career Enhancement The CCSG budget supports technological and operational expansion for a talented faculty integrated through cancer center mechanisms towards making advancements in the prevention, early detection, and treatment of cancer in North Carolina and the nation.